Not Yet Recruiting
Gemox Combined With Anlotinib and Sintilimab in Advanced cHCC-ICC
NCT06033118
- Conditions
- Combined Hepatocellular Cholangiocarcinoma
- Locations
-
Not specified
Clinical trial condition
Combined Hepatocellular Cholangiocarcinoma
Explore clinical trials studying Combined Hepatocellular Cholangiocarcinoma. Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies